FPSUF (Capha Pharmaceuticals) Common Stock: $8.38 Mil (As of Jun. 2025)


What is Capha Pharmaceuticals Common Stock?

Capha Pharmaceuticals FPSUF Common Stock is $8.38 Mil as of Jun. 2025.

Capha Pharmaceuticals's quarterly common stock declined from Dec. 2024 ($8.04 Mil) to Mar. 2025 ($7.98 Mil) but then increased from Mar. 2025 ($7.98 Mil) to Jun. 2025 ($8.38 Mil).

Capha Pharmaceuticals's annual common stock increased from Dec. 2022 ($8.43 Mil) to Dec. 2023 ($8.54 Mil) but then declined from Dec. 2023 ($8.54 Mil) to Dec. 2024 ($8.04 Mil).

Capha Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Capha Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capha Pharmaceuticals Common Stock Chart

Capha Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.94 8.95 8.43 8.54 8.04

Capha Pharmaceuticals Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.36 8.46 8.04 7.98 8.38

Capha Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $8.38 Mil mean?
Capha Pharmaceuticals (FPSUF) has a Common Stock of $8.38 Mil as of Jun. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Capha Pharmaceuticals and its competitors.
Is Capha Pharmaceuticals' Common Stock too high?
Capha Pharmaceuticals' current Common Stock is $8.38 Mil.
How does Capha Pharmaceuticals' Common Stock compare to GRYN and TAUG?
Capha Pharmaceuticals' Common Stock of $8.38 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Capha Pharmaceuticals and its competitors. Capha Pharmaceuticals's current Common Stock is $8.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capha Pharmaceuticals stock overvalued right now?
Capha Pharmaceuticals (FPSUF) has a current Common Stock of $8.38 Mil. The current Common Stock is $8.38 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Capha Pharmaceuticals (FPSUF), the current Common Stock is $8.38 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Capha Pharmaceuticals Business Description

Address 4205 Gellatly Road, Suite 324, West Kelowna, BC, CAN, V4T 2K2
Capha Pharmaceuticals Inc is a Canada-based company principally operating in the pharmaceutical industry. The company produces and distributes products in Canada and the United States of America.